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Spinal cord injury (SCI) represents a significant health and social problem, and therefore it is vital to develop
novel strategies that can specifically target it. In this context, the objective of the present work was to develop a
new range of three-dimensional (3D) tubular structures aimed at inducing the regeneration within SCI sites. Up
to six different 3D tubular structures were initially developed by rapid prototyping: 3D bioplotting–based on a
biodegradable blend of starch. These structures were then further complemented by injecting Gellan Gum, a
polysaccharide-based hydrogel, in the central area of structures. The mechanical properties of these structures
were assessed using dynamic mechanical analysis, under both dry and wet conditions, and their morphologies=
porosities were analyzed using micro-computed tomography and scanning electron microscopy. Biological
evaluation was carried out to determine their cytotoxicity, using both minimum essential medium (MEM)
extraction and MTS tests, as well as by encapsulation of an oligodendrocyte-like cell (M03-13 cell line) within the
hydrogel phase. The histomorphometric analysis showed a fully interconnected network of pores with porosity
ranging from 70% to 85%. Scaffolds presented compressive modulus ranging from 17.4 to 62.0MPa and 4.42 to
27.4MPa under dry and wet conditions, respectively. Cytotoxicity assays revealed that the hybrid starch=poly-e-
caprolactone=Gellan Gum scaffolds were noncytotoxic, as they did not cause major alterations on cell mor-
phology, proliferation, and metabolic viability. Moreover, preliminary cell encapsulation assays showed that the
hybrid scaffolds could support the in vitro culture of oligodendrocyte-like cells. Finally, preliminary in vivo
studies conducted in a hemisection rat SCI model revealed that the above-referred structures were well inte-
grated within the injury and did not trigger chronic inflammatory processes. The results herein presented
indicate that these 3D systems might be of use in future SCI regeneration approaches.
Introduction
Spinal cord injury (SCI) results in a devastating con-dition with enormous financial,1–4 social, and personal
costs.5 It is estimated that the annual incidence of SCI in the
United States alone is approximately 40 cases per 1 million. It
is commonly characterized by a primary injury that leads to
a cascade of cellular and biochemical reactions that cause
further damage. The latter is known as ‘‘secondary injury,’’
which is characterized by microvascular alterations, edema,
ischemia, necrosis, free radicals formation, lipid peroxida-
tion, excitatory neurotransmitter accumulation, inflamma-
tory response, and other molecular changes contributing to
further neural damage.2,6–9
Current approaches used in clinical practice are mainly
based on the use of pharmacological agents, like methyl-
prednisolone.10,11 However, its use is quite controversial, as
recent studies failed to reveal conclusive beneficial out-
comes.12,13 Therefore, it is imperative to find novel thera-
peutic strategies that can specifically target SCI regeneration.
In recent years, different approaches have been proposed
to develop valid strategies for SCI repair such as biomolec-
ular,14–17 cellular,18–23 and biomaterial-based therapies.24–28
However, due to the complexity of SCI repair it is unlikely
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that a single strategy will be adequate to tackle the problem.
It is probable that only by following an integrated strategy,
such as that presented by tissue engineering,29 it will be
possible to develop a successful approach. In this field, it is of
general agreement that a scaffold, a three-dimensional (3D)
biodegradable structure, plays a central role in the aid of the
regenerative process. In recent years, natural-based biode-
gradable polymers have emerged as a possible biomaterial
source for scaffold development within the SCI field.28,30–34
Among these, polysaccharides are particularly appealing
owing to their structural similarities to components of host
tissues. Moreover, they can also be enzymatically degraded
in biological systems, allowing for better control of endoge-
nous degradation rate along with other properties.35,36
Within the present study we aimed at developing a new
bi-phasic tubular scaffold for SCI regeneration. It is com-
prised of two natural polysaccharide-based biomaterials:
starch=poly-e-caprolactone (SPCL) blend and gellan gum.
SPCL has been originally proposed by Reis and colleagues
for a wide range of applications, including the culture
of neurons, astrocytes, and oligodendrocytes.37–43 Gellan
gum is an anionic exocellular polysaccharide secreted from
the Sphingomonas paucimobilis bacterium. It is composed of
repeated tetrasaccharide units of glucose, glucuronic acid,
and rhamnose residues in a 2:1:1 ratio.44 It was originally
used as a thickener=gelling agent in food applications, and
was recently proposed as a hydrogel for regenerative medi-
cine purposes.44 The hybrid structures proposed in this re-
port consist of an SPCL semi-rigid tubular porous structure
filled by a gellan gum hydrogel concentric core. In this
concept the SPCL tubular structure assures mechanical sta-
bility to the entire construct, namely, by establishing a con-
nection to the adjacent vertebral bone. In this sense the SPCL
phase is aimed at mimicking the bone functions, while the
gellan gum hydrogel is used as a cell encapsulation system to
support axonal regeneration in the injured spinal cord.
In this report we address the mechanical and preliminary
biological characterization of SPCL=gellan gum hybrid
tubular structures. Our results reveal that these novel
structures exhibit adjustable mechanical performance and
porosity with minimal cytotoxicity and support the encap-
sulation of oligodendrocyte-like cells. Moreover, it was also
observed that these 3D hybrid structures caused a minimal
inflammatory reaction when implanted subcutaneously and
in a hemisection SCI model in Wistar rats.
Materials and Methods
Materials
The materials used in this work were a 30=70 (wt%) bio-
degradable blend of SPCL and a polysaccharide gellan gum
hydrogel 1% (w=v) (Sigma, St. Louis, MO).
Development of SPCL tubular scaffolds
The SPCL tubular scaffolds were processed in a two-step
methodological approach:
(1) Porous sheets featuring different pore geometries were
produced by 3D plotting rapid prototyping (Bio-
plotter; Envisiontec GmbH,Marl, Germany)45,46 using
two different interfilament orientations (908 and 458).
(2) Tubular scaffolds were obtained by rolling up porous
sheets around a cylinder with subsequent heat treat-
ment at 658C for 30min to induce the adhesion be-
tween filaments.
Up to six different porous tubular scaffold designs were
obtained featuring a single or double layer combined with
three different filaments’ oriented relative to the tube main
axis: filaments oriented at 08 and 908 relative to the tube main
axis (90=1–2, further referred as 90=1 and 90=2 for structures
with one or two layers), filaments oriented at 08 and 458
relative to the tube main axis (45=1–2, further referred as
45=1 and 45=2), and filaments oriented at 458 relative to the
tube main axis (X=1–2, further referred as X=1 and X=2). As
an example of the adopted scaffold references, processing
combination 90=2 refers to a double-layer scaffold featuring
filaments orientated at 08 and 908 relative to the tube main
axis, while 45=1 refers to a single-layer scaffold featuring
filaments orientated at 458 relative to the tube main axis.
Scanning electron microscopy
Scanning electron microscopy was used for analysis of
morphology=porosity of the different SPCL tubular scaf-
folds. For this purpose, all samples were coated with Au=Pd
via ion-sputtering before observation in a Stereoscan 360
scanning electron microscope (Leica Cambridge Co., Cam-
bridge, United Kingdom).
Micro-computed tomography
The architecture and porosity of the tubular scaffolds were
analyzed by micro-computed tomography (m-CT) using a
desktop m-CT scanner (1072; SkyScan, Kontich, Belgium) at a
voltage of 40 kV and a current of 248mA. Isotropic slice data
were obtained by the system and reconstructed into 2D XY
slice images. Around 600 slice images per sample were
compiled and subsequently employed in the rendering of 3D
XYZ images to obtain quantitative architectural parameters.
A m-CT analyzer and a m-CT volume realistic 3D Visualiza-
tion software (SkyScan) was used as an image processing
tool for reconstruction and creation=observation of 3D scaf-
fold representations.
Dynamic mechanical analysis
Dynamic mechanical analysis was carried out using a
uniaxial compression-loading scheme at 378C, under both
dry and wet (phosphate buffered saline 0.1M, pH 7.2) con-
ditions. Dynamic mechanical analysis was performed in a
Tritec 2000B equipment (Triton Technology, Nottingham-
shire, UK). The frequency ranged between 1 and 70Hz.
Three replicates were conducted for each type of scaffold
morphology.
Development of the 3D hybrid systems
The integration of gellan gum hydrogel into the central
canal of the SPCL tubular scaffolds was performed by plac-
ing the tubular scaffolds into a specially designed mold, and
by filling the empty volume with a gellan gum hydrogel as
previously described by Oliveira et al.44
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In vitro cytotoxicity assessment
To assess the short-term cytotoxicity of the developed
scaffolds, the following guidelines described by Salgado et al.
were used47: minimum essential medium (MEM) extraction
and MTS tests, both with 7, 14, 21, and 28 days of extraction
period. In all tests material weight–to–extract fluid ratio was
constant and equal to 0.2 g=mL for porous samples, whereas
for latex (negative control for cell viability) the ratio of ma-
terial outer surface to extraction fluid was 2.5 cm2=mL. After
each period the extracts were filtered through a 0.45-mm-
pore-size filter. These assays are particularly suitable for as-
sessing the possible toxic effect of leachables extracted from
biomedical polymers. The objectives of the MEM extraction
test are to evaluate changes in cell morphology and growth
inhibition, whereas the MTS test determines whether cells
are metabolically viable. In both cases, latex extracts (same
extraction periods) were used as positive controls for cell
death, while standard culture medium (formulation de-
scribed bellow) was used as negative control for cell death.
Cell culture. The present experiment used a cell line of
rat lung fibroblasts-L929, obtained from the European Col-
lection of Cell Cultures. Cells were grown as monolayers in
Dulbecco’s modified Eagle’s medium (DMEM; Sigma), sup-
plementedwith10%fetalbovineserum(FBS;Gibco,Barcelona,
Spain) and 1% of an antibiotic–antimycotic mixture (Sigma).
For the MEM extraction tests, cells were seeded in 12-well
plates (n¼ 3, 1105 cells=well), whereas for the MTS test,
cells were seeded in 96-well plates (n¼ 3, 1.8104 cells=well).
In both cases cells were incubated for 24 h at 378C in a 5%
(v=v) CO2 cell culture incubator.
MEM extraction test. Twenty-four hours after cell seed-
ing, the culture medium was removed from the wells and an
identical volume, 1mL, of extraction fluid was added. Cul-
tures were then incubated with the extracts for 72 h, after
which a live=dead assay was conducted by staining live cells
with calcein-AM (1mg=mL; Molecular Probes, Eugene, OR)
and nonviable cells with propidium iodide (0.1mg=mL;
Molecular Probes). Upon staining, cultures were observed
under a fluorescence microscope (BX-61; Olympus, Ham-
burg, Germany).
MTS test. The metabolic viability of the L929 cells after
exposure to extracts was determined by the bioreduction
of [3-(4,5-dimethylthiazol-2-yl)-5-(3carboxymethoxyphenyl)-
2-(4-sulfophenyl)-2H-tetrazolium] (MTS; Promega, Madison,
WI) into a brown formazan product by dehydrogenase en-
zymes. The extraction procedure was performed as previ-
ously described, using, in this turn, 200mL of extraction fluid
per well.47 After 72 h of incubation, extracts were removed
and a mixture of DMEM with MTS (5:1 ratio) was added to
each well. Cells were then incubated for 3 h at 378C in a 5%
CO2 cell culture incubator after which optic density (OD)
was determined at 450 nm using a 96-well plate reader (Te-
can Sunrise, Ma¨nnedorf, Switzerland).
Histocompatibility evaluation
Subcutaneous implantation. Young male Wistar rats (8
weeks old) were purchased from Charles River, housed in
light- and temperature-controlled rooms, and fed a standard
diet. The maintenance and manipulation of animals were in
accordance with standardized Animal Care Guidelines.48
Hybrid 3D tubular scaffolds with one and two layers were
implanted subcutaneously in the back of the animals for 7,
14, 21, and 28 days. At the end of the implantation period,
rats were sacrificed. The scaffolds were removed from the
animals, fixed in 3.7% formalin, embedded in Technovit
7100 (Kuzere, Wehrheim, Germany), and processed for
hematoxylin–eosin staining.
Hemisection SCI model
Young male Wistar rats (8 weeks old) were purchased
from Charles River, housed in light- and temperature-
controlled rooms, and fed a standard diet. The maintenance
and manipulation of animals were in accordance with stan-
dardized Animal Care Guidelines.48 To expose the spinal
cord a laminectomy was performed at T8–T9 level. Once
exposed, an unilateral defect was performed on the spinal
cord, by removing approximately 2–3mm of the latter. After
this the 3D semi-tubular scaffolds were implanted in the
defect site, with the SPCL phase aligned with the vertebral
while the gellan gum was facing, and filling, the injured
spinal cord. The scaffolds were removed from the animals,
fixed in 3.7% formalin, decalcified, paraffin embedded, and
finally processed for hematoxylin–eosin staining.
Encapsulation assays
For the cell encapsulation experiments within the gellan
gum hydrogel, the human oligodendrocyte cell line MO3-13
was used. For this purpose, cells were grown as monolayer
cultures in DMEM supplemented with 10% FBS and 1%
antibiotic–antimycotic mixture until confluence. At this time
cells were encapsulated in two different cellular densities (8
and 20104 cells=mL) and injected into central canal of SPCL
tubular scaffolds. Cell=scaffold constructs were then incu-
bated in culture medium (DMEM, Gibco; 10% FBS, Gibco;
1% antibiotic=antimycotic, Sigma) for 7 days at 378C in a 5%
(v=v) CO2 cell culture incubator. For this period, the distri-
bution of viable cells was evaluated by confocal microscopy
in combination with calcein-AM staining (Fluoview FV 1000;
Olympus).
Statistical analysis
Statistical evaluation was performed using the one-way
analysis of variance test followed by the Tukey posttest, to
assess the statistical differences between groups in the po-
rosity and cytotoxicity analyses. Evaluation of statistical
differences on mechanical tests was performed using a two-
way analysis of variance test followed by a Bonferroni
posttest. Statistical significance was defined for p< 0.05.
Results and Discussion
The objective of this work was to develop a novel bi-
phasic 3D tubular structure composed of a biodegradable
semirigid polymer and a hydrogel-like material. Comparing
with other currently used strategies for scaffold-based SCI
repair, our scaffold design has the advantages of combining
the guidance stabilization from the 3D tubes, including the
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regeneration of vertebral bone, with the amenable conditions
of a hydrogel-based material for cell and tissue migration. In
this sense, our novel scaffold combines the beneficial effects
of both strategies, overcoming the limitations of each strat-
egy by itself. For instance, guidance tubes are able to stabilize
the injured area from the mechanical point of view, while
they act simultaneously as a physical guidance for SCI re-
generation and protect the regenerating area from the inva-
sion of adjacent connective tissue.2 However, often this
guidance tubes lack the signaling cues, which, as described
by Misgeld and coworkers,49 allow a more efficient cell and
tissue migration along the injured area. Regarding hydro-
gels, it is known that they are quite versatile for SCI appli-
cations due to their cell encapsulation properties, peptide
grafting, and growth factor loading.28 Nevertheless, in con-
trary to guidance tubes, hydrogels do not stabilize the in-
jured area and have a limited capacity to avoid infiltration by
the surrounding tissue.28 The chosen biomaterials for the
development of the 3D bi-phasic scaffolds have also several
others advantages. Both of them are polysaccharides prone
to normal degradation in vivo, and both SPCL and gellan
gum are easily integrated in different tissues. For instance,
SPCL has been previously shown to allow the formation of
bone extracellular matrix in vitro and bone in vivo,39,41 which
is one of the main objectives of the SPCL phase under the
concept herein presented. Further, this thermoplastic bio-
material is quite versatile from the processing point of view,
allowing the use of rapid prototyping technologies for the
development of the tubular structure. This is advantageous,
as rapid prototyping (RP) allows the processing of highly
reproducible scaffolds. On the other hand, gellan gum rap-
idly polymerize either at room temperature or at 378C, which
allows the encapsulation of relevant cell populations50,51
without compromising their viability, as shown in the pres-
ent article (see below). Moreover, gellan gum is quite ame-
nable for chemical modification, and thus is makes possible
to graft and align relevant peptides that can promote axonal
migration, such as RGD and YISGS. For this purpose stan-
dard aqueous-phase peptide synthesis methodologies can be
used on the polysaccharide backbone to promote adequate
FIG. 1. Starch=poly-e-caprolactone (SPCL) tubular scaffolds. (a) Micro-computed tomography (m-CT) image of 90=1 type
structure. (b) Scanning electron microscopy (SEM) of 90=2 type structure. (c) m-CT image of 45=1 type structure. (d) SEM of
45=2 type structure. (e) m-CT image of X=1 type structure. (f) SEM of X=2 type structure. (g) m-CT image of the top view of
two-layer-type scaffolds. (h) SEM of the top view of one-layer-type scaffolds.
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binding of the sequences of interest to the gellan gum. This
can be achieved by activating the carboxylic groups of the
sugar molecules with carbodiimide and then conjugating it
with amino groups of methylester protected amino acids to
which the presynthesized sequence of interest will be bound.
To develop the 3D guidance structure, a tubular scaffold
was developed by combining rapid prototyping with a
postprocessing thermal treatment. As it can be observed in
Figure 1, the proposed processingmethodologywas quite ver-
satile, allowing for the development of 3D tubular scaffolds
FIG. 2. Percentage values of
porosity of each structure type.
Mean SD (n¼ 3). ***Statis-
tical significance for p< 0.001.
SD, standard deviation.
FIG. 3. Dynamic mechanical analysis of each scaffold type developed. (a) Dry compressive modulus evaluation in function
of frequency. (b) Wet compressive modulus evaluation in function of frequency. (c) Rigidity comparison at 1Hz in dry
conditions. (d) Rigidity comparison at 1Hz in wet conditions. (e) Comparison at 1Hz between the dry and wet tests.
Mean SD (n¼ 3). Statistical significance for ***p< 0.001, **p< 0.01, and *p> 0.05.
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with configurable outer layer thickness, fiber=filament ori-
entation, and pore geometry. Fiber orientation ranged from
08 to 908 and resulted from the design adopted during the
rapid prototyping stage.
Morphological analysis conducted by scanning electron
microscopy and m-CT demonstrated that the developed
processing technique allowed the production of structures
with a precise tubular geometry with fully interconnected
pore networks. Further analysis conducted using m-CT re-
vealed that scaffolds had fully interconnected network of
pores with approximately 85% porosity for structures fea-
turing a single outer layer and around 71% porosity for
structures featuring double outer layers (Fig. 2). The differ-
ences in porosity observed were related to the outer thickness
of the SPCL tubular structures, as the different orientations
of the fibers did not affect the overall porosity of the scaf-
folds. The porosity values are in the range of those found in
the literature for similar purposes.52
To assess their mechanical properties, the different tubular
scaffolds were subjected to dynamic compression testing.
The objective of these experiments was to evaluate their
mechanical integrity and simultaneously determine their
respective stiffness. Tests were carried out, at 378C in dry
and wet conditions, to simulate and study the influence of
physiologic conditions on the mechanical properties of the
tubular scaffolds, namely the influence of water absorption.
Moreover, to detect eventual mechanical collapse of the
structure or layer detachment, the scaffolds were submitted
to an increasing frequency test. Nevertheless, no major var-
iation of storage modulus was detected upon the increase of
frequency (Fig. 3a, b), which testifies the resilience of the
scaffolds developed. Dry and wet tests revealed significant
differences in the stiffness of the developed scaffolds. In the
dry tests the 90=2 samples obtained the highest value, fol-
lowed in decreasing order of magnitude by structures 45=2,
90=1, X=2, 45=1, and X=1 (Fig. 3c, p< 0,05). Under wet con-
ditions, as it would be expected, there was a decrease in
stiffness. Consistent with the dry test observations, condi-
tions 90=2 and 45=2 had the highest values. However, in this
case, the third condition that presented higher stiffness was
X=2 followed by 90=1, 45=1, and X=1 (Fig. 3d). The stiffness of
the different tubular scaffolds at 1Hz under dry and wet
conditions is plotted in Figure 3e. The differences observed
were related with different fiber orientations and scaffold
thicknesses. Scaffolds with two layers had higher stiffness
values than the equivalent single-layer structures. On what
concerns to fiber orientation, scaffolds with aligned fibers
along the tube axis had higher resistance to compression
force. Our results revealed that, 90=1 and 90=2, as well as
45=1 and 45=2 conditions contained higher stiffness values
than those of X=1 and X=2 structures. For 90=1–2 and 45=1–2
scaffolds, half of the fibers were aligned in the same direction
FIG. 4. First generation of functionalized multi supportive structure (FMSS). (a) After maintaining in culture with Dul-
becco’s modified Eagle’s medium. (b) FMSS loupe view (10). Color images available online at www.liebertonline.com=ten.
FIG. 5. MEM extraction eval-
uation of cell line L929 for
four times of incubation (7, 14,
21, and 28 days) with three
different conditions (positive
control, negative control, and
FMSS extract). Viable cells
were staining with calcein-
AM and unviable cells stain-
ing with propidium iodide.
Color images available online
at www.liebertonline.com=ten.
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of the applied compression force. However, while for 90=1–2
scaffolds, approximately half of the fibers were aligned or-
thogonally to the compression force; for 45=1–2 conditions,
the remaining half were diagonally aligned (458 relative to the
compression force). In theory, 45=1–2 and X=1–2 conditions
should present higher stiffness than those experimentally
observed, due to the stiffness contribution of diagonally ori-
entated fibers—cosine (458). The lower values of stiffness
observed for scaffolds featuring diagonally orientated struc-
tures are probably due to buckling of the structure, which
occurs upon compression due to geometrical instability of
the structure. As previously shown (Fig. 3e), under wet con-
ditions, all scaffolds exhibited a decrease in stiffness, which
can be explained by the water absorption. Water acts as
plasticicer of the polymer, reducing its resistance to plastic
deformation.53 In SPCL, starch is the main water absorbent
since PCL has low water uptake ability.53
Further, it could also be observed that the relative decrease
in stiffness was larger in single-layer structures. This can be
explained by the larger surface area=total volume ratio of
single-layered structures as compared to double-layered
structures. In double-layered scaffolds, the stacking of po-
rous sheets reduces the relative surface area, which ulti-
mately results in less water absorption. It is important to note
that the mechanical tests with the SPCL structures were
performed before gellan gum incorporation. Since the stiff-
ness of gellan gum hydrogel is three orders of magnitude
smaller than SPCL, no relevant mechanical effect would be
expected for structures containing the hydrogel. Under dry
conditions, the elastic modulus for gellan gum was deter-
mined to be 79.7 7.56 kPa, as characterized by Oliveira
et al.44
Following the physical characterization of tubular scaf-
folds, the hydrogel phase was injected into the central canal
of the tubes. This process allowed the formation of the bi-
phasic structure presented in Figure 4. As it can be observed,
the two phases were fully integrated in the system, being the
central canal of the 3D SPCL tubular structure entirely filled
with the gellan gum hydrogel. The main benefit of the pro-
posed hybrid system arises from the individual potential
advantages of each material. The SPCL frame is aimed at
assuring the structural stiffness of the construct, while the
gellan gum hydrogel is expected to create an amenable nerve
regeneration environment.
Biological assays were performed upon the development
of the hybrid SPCL=gellan gum structures. Their cytotoxicity
was determined by MTS and MEM extraction tests on a L929
cell line, while cell encapsulation assays were carried out
with an oligodendrocyte-derived cell line. Since the SCPL
layer will be used to connect to adjacent bone, the stiffness of
the SPCL tubular structures is very important, as they will
FIG. 6. MTS evaluation for cell line L929 for four times of
incubation (7, 14, 21, and 28 days) with three different con-
ditions (positive, Dulbecco’s modified Eagle’s medium
[DMEM]; negative, Latex [controls and FMSS extract]).
Mean SD (n¼ 3). ***Statistical significance for p< 0.001.
FIG. 7. Scaffolds were im-
planted in a subcutaneous
(a, b) and hemisection (c, d)
spinal cord injury model.
In both cases histological
sections were stained with
hematoxylin–eosin. After 1 (a)
and 4 (b) weeks of subcuta-
neous implantation, the tested
hybrid scaffolds were well
integrated within the sur-
rounding tissue with minimal
inflammatory response. Simi-
lar results were also obtained
for the hemisection model (c,
d), where it could be observed
the formation of bone near
SPCL struts. Color images
available online at www
.liebertonline.com=ten.
DEVELOPMENT AND CHARACTERIZATION HYBRID SCAFFOLDS FOR SCI REPAIR 51
support directly the development of a mineralized tissue. In
this sense, from all the developed structures, 90=2 samples
were chosen for biological assays, as these present the best
mechanical performance. Regarding cytotoxicity assays,
MEM extraction tests associated with calcein=propidium io-
dide staining revealed that the extracts obtained from the
hybrid 3D tubular structures did not cause cell death among
L929 cells. The cell density, morphology, and viability were
very similar between the extracted incubated cells and the
cells grown in DMEM (positive control) (Fig. 5). These results
were in contrast to cells grown in latex, and were then fur-
ther confirmed by the MTS test (Fig. 6), under which L929
cells produced large amounts of a brown formazan product
after incubation with the tested extracts. This is an indicator
of normal metabolism as they were able to incorporate and
metabolize MTS. MTS incorporation under these conditions
was similar to the negative control and thus supportive of a
lack of cytotoxic effect of these hybrid structures.
These favorable results were further confirmed by pre-
liminary in vivo tests. In this case the 3D tubular hybrid
structures were either subcutaneously implanted on Wistar
rats (Fig. 7a, b) or in a hemisection model of SCI (Fig. 7c, d).
In the subcutaneous model, rats developed an initial, but
mild, inflammatory reaction detected after 1 week of im-
plantation (Fig. 7a), which faded by the 4th week (Fig. 7b),
indicating a possible biocompatible character of the scaffolds.
Moreover, we also observed no formation of fibrotic cap-
sules, supportive of the lack of inflammatory response trig-
gered by the implanted scaffolds. Finally, it was possible to
confirm that pore size, geometry, and properties of the
structure facilitated cells and connective tissue penetration
within the scaffold. Similar results were also obtained for the
SCI model, regarding the inflammatory response. As it can
be seen in Figure 7c and d, no major inflammation processes
were found. Moreover, it was possible to observe bone tissue
(Fig. 7c) forming around SPCL struts. Nevertheless, the re-
sults of this preliminary experiment will be further con-
firmed in future experiments.
The interaction of central nervous system cell populations
with the developed structures is extremely important since
they will be one of the mediators of nerve regeneration in-
duction within the hydrogel phase. Therefore, preliminary
cell encapsulation assays were performed using the MO3-13
human oligodendrocyte cell line. The rationale for using
these cells was based on future approaches that can be used,
namely, the use of oligodendrocyte progenitors to foster re-
myelination repair in the affected SCI areas. As previously
described, the cell population was first encapsulated within
the gellan gum hydrogel before injection in the tubular
structure. Confocal laser microscopy observation revealed
that the hydrogel phase of the hybrid structure supported
the in vitro culture of MO3-13 cells during the culturing pe-
riod (up to 1 week). The cells were preferentially dispersed
within the gellan gum matrix, being either at the center (Fig.
8a) or at the vicinities (Fig. 8b) of the hydrogel.
Conclusions
With the present work it was possible to show that 3D
plotting, a rapid prototyping technology, was successfully
used in the development of starch-based scaffolds to be
employed in future applications for SCI regeneration. We
also showed that the developed SPCL tubular scaffolds
possessed configurable mechanical performance, pore sizes,
and interconnectivity values adequate for cell=tissue-based
regenerative applications. We also demonstrated that the
different orientations of the fibers and the number of layers
in the developed structures influenced their mechanical
properties. Moreover, we demonstrated that SPCL=gellan
gum hybrid structures were noncytotoxic and disclosed an
apparent biocompatible response in vivo. Finally, it was also
possible to observe that these structures allowed the in vitro
culture of oligodendrocyte-like cells for periods up to 1 week.
Further work is ongoing using these hybrid systems in ani-
mal models, to determine their potential to therapeutic in-
tervention of SCI, as well the functionality of improved of
gellan gum hydrogels in terms of cell adhesion and guidance
upon division.
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